{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:49:54Z","timestamp":1793364594102,"version":"4.5.0"},"reference-count":152,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jceh.2014.10.002","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T05:43:44Z","timestamp":1414647824000},"page":"332-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":243,"title":["Sinusoidal Obstruction Syndrome (Hepatic Veno-Occlusive Disease)"],"prefix":"10.1016","volume":"4","author":[{"given":"Cathy Q.","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2014.10.002_bib1","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/00000441-190512000-00005","article-title":"Fatal obliterative endophlebitis of the hepatic vein","volume":"130","author":"Hess","year":"1905","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jceh.2014.10.002_bib2","first-page":"285","article-title":"Veno-occlusive disease of liver with nonportal type of cirrhosis, occurring in Jamaica","volume":"57","author":"Bras","year":"1954","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jceh.2014.10.002_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1126\/science.114.2960.303","article-title":"Liver cirrhosis with ascites, induced in dogs by chronic massive hepatic irradiation with radioactive colloidal gold","volume":"114","author":"Hahn","year":"1951","journal-title":"Science"},{"key":"10.1016\/j.jceh.2014.10.002_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/adc.37.195.535","article-title":"The early lesions in veno-occlusive disease of the liver","volume":"37","author":"Stirling","year":"1962","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jceh.2014.10.002_bib5","series-title":"Fetal and Infant Liver Function and Structure","first-page":"392","article-title":"Toxic factors in veno-occlusive disease","volume":"Vol. 111","author":"Bras","year":"1963"},{"key":"10.1016\/j.jceh.2014.10.002_bib6","first-page":"240","article-title":"Hepatic injury following irradiation \u2013 a morphologic study","volume":"9","author":"Ogata","year":"1963","journal-title":"Tokushima J Exp Med"},{"key":"10.1016\/j.jceh.2014.10.002_bib7","first-page":"597","article-title":"The human liver after radiation injury: a form of veno-occlusive disease","volume":"48","author":"Reed","year":"1966","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jceh.2014.10.002_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/path.1700790220","article-title":"Chiari's disease and the Budd-Chiari syndrome","volume":"79","author":"Gibson","year":"1960","journal-title":"J\u00a0Path Bact"},{"key":"10.1016\/j.jceh.2014.10.002_bib9","first-page":"379","article-title":"Congestive splenomegaly (Banti's syndrome) due to portal stenosis","volume":"67","author":"Shillam","year":"1947","journal-title":"Calif Med"},{"key":"10.1016\/j.jceh.2014.10.002_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(76)90727-3","article-title":"An epidemic of hepatic veno-occlusive disease in central India","volume":"ii","author":"Tandon","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2014.10.002_bib11","first-page":"339","article-title":"Veno-occlusive disease and primary hepatic vein thrombosis in Israeli Arabs","volume":"17","author":"Ghanem","year":"1981","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.jceh.2014.10.002_bib12","first-page":"14","article-title":"An experimental study of Senecio poisoning in rats","volume":"32","author":"Selzer","year":"1951","journal-title":"Br J Exp Path"},{"key":"10.1016\/j.jceh.2014.10.002_bib13","first-page":"242","article-title":"Veno-occlusive lesions in livers of rats fed Crotolaria fulva","volume":"45","author":"McLean","year":"1964","journal-title":"Br J Exp Path"},{"key":"10.1016\/j.jceh.2014.10.002_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0031-6997(25)06884-X","article-title":"The toxic actions of pyrrolizidine (Senecio) alkaloids","volume":"22","author":"McLean","year":"1970","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jceh.2014.10.002_bib15","first-page":"1521","article-title":"Bone marrow transplantation in acute leukemia","volume":"25","author":"Thomas","year":"1965","journal-title":"Cancer Res"},{"key":"10.1016\/j.jceh.2014.10.002_bib16","first-page":"5","article-title":"Fatal veno-occlusive disease of the liver after chemotherapy, whole-body irradiation and bone marrow transplantation for refractory anemia","volume":"55","author":"Jacobs","year":"1979","journal-title":"S\u00a0Afr Med J"},{"key":"10.1016\/j.jceh.2014.10.002_bib17","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/0016-5085(80)90911-7","article-title":"An analysis of hepatic veno-occlusive disease and centrilobular hepatic degeneration following bone marrow transplantation","volume":"79","author":"Shulman","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2014.10.002_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0002-9343(80)90368-X","article-title":"Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantation","volume":"68","author":"Woods","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.jceh.2014.10.002_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.10.002_bib20","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1200\/JCO.1990.8.10.1699","article-title":"Hepatic veno-occlusive disease in autologous bone marrow transplantation of solid tumors and lymphomas","volume":"8","author":"Ayash","year":"1990","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jceh.2014.10.002_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01600293","article-title":"Focal veno-occlusive lesions following metastasis of cancer in the liver with special reference to obstruction of lymphatics in hepatic veins","volume":"418","author":"Shibayama","year":"1991","journal-title":"Virchows Arch [A]"},{"key":"10.1016\/j.jceh.2014.10.002_bib22","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Veno-occlussive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.10.002_bib23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/00007890-198706000-00020","article-title":"Veno-occlusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation","volume":"43","author":"Dulley","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.10.002_bib24","first-page":"53","article-title":"Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome","volume":"3","author":"Brugieres","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/roi.2970010505","article-title":"Tolerance of rhesus monkey liver to ionizing radiation","volume":"1","author":"Stephens","year":"1994","journal-title":"Radiat Oncol Invest"},{"key":"10.1016\/j.jceh.2014.10.002_bib26","first-page":"279","article-title":"Hepatic veins of monkeys with veno-occlusive disease. Sequential ultrastructural changes","volume":"87","author":"Allen","year":"1969","journal-title":"Arch Pathol"},{"key":"10.1016\/j.jceh.2014.10.002_bib27","first-page":"114","article-title":"Induction of hepatic veno-occlusive disease in dogs","volume":"126","author":"Shulman","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jceh.2014.10.002_bib28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.1840190515","article-title":"Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms","volume":"19","author":"Shulman","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.10.002_bib29","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.10.002_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (venoocclusive disease)","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2014.10.002_bib31","doi-asserted-by":"crossref","first-page":"G1045","DOI":"10.1152\/ajpgi.00526.2002","article-title":"Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome","volume":"284","author":"DeLeve","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jceh.2014.10.002_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","article-title":"Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome","volume":"23","author":"Helmy","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2014.10.002_bib33","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","article-title":"Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation","volume":"104","author":"Srivastava","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2014.10.002_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/bjc.2012.590","article-title":"Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer","volume":"108","author":"Vreuls","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jceh.2014.10.002_bib35","first-page":"218A","article-title":"Decrease in nitric oxide production contributes to hepatic venoocclusive disease","volume":"30","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.10.002_bib36","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/hep.1840380416","article-title":"Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome","volume":"38","author":"DeLeve","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.10.002_bib37","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/ar.a.20092","article-title":"Innervation of the sinusoidal wall: regulation of the sinusoidal diameter","volume":"280","author":"Ueno","year":"2004","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"10.1016\/j.jceh.2014.10.002_bib38","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0016-5085(03)01056-4","article-title":"Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition","volume":"125","author":"DeLeve","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2014.10.002_bib39","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1053\/j.gastro.2009.05.009","article-title":"Bone marrow progenitor cells repair hepatic sinusoidal endothelial cells after liver injury","volume":"137","author":"Harb","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2014.10.002_bib40","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/sj.bmt.1703061","article-title":"Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation","volume":"27","author":"Iguchi","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib41","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2012.07.004","article-title":"Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9","volume":"57","author":"Nakamura","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.10.002_bib42","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.10.002_bib43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","article-title":"New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis","volume":"53","author":"Wang","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.10.002_bib44","article-title":"A\u00a0nonhuman primate model of human radiation-induced venoocclusive liver disease and hepatocyte injury","author":"Yannam","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jceh.2014.10.002_bib45","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jceh.2014.10.002_bib46","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2013.04.014","article-title":"Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model","volume":"59","author":"Robinson","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.10.002_bib47","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/bjc.2013.604","article-title":"The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome","volume":"109","author":"Robinson","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jceh.2014.10.002_bib48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s12013-013-9587-7","article-title":"A\u00a0murine model of hepatic veno-occlusive disease induced by allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Zeng","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.jceh.2014.10.002_bib49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1535-7163.MCT-10-1072","article-title":"Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans","volume":"10","author":"Rubbia-Brandt","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jceh.2014.10.002_bib50","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1245\/s10434-011-2112-6","article-title":"Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization","volume":"19","author":"Narita","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jceh.2014.10.002_bib51","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/sj.bmt.1703014","article-title":"Avoiding hepatic veno-occlusive disease: what do we know and where are we going?","volume":"27","author":"Bearman","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib52","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-2008-1040578","article-title":"Liver disease after human marrow transplantation","volume":"7","author":"McDonald","year":"1987","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2014.10.002_bib53","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bmt.1701994","article-title":"Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation","volume":"24","author":"Toh","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib54","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.transproceed.2005.03.025","article-title":"Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years","volume":"37","author":"Kalayoglu-Besisik","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2014.10.002_bib55","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.leukres.2013.06.024","article-title":"Hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation in adult patients with idiopathic aplastic anemia","volume":"37","author":"Kim","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.jceh.2014.10.002_bib56","series-title":"The Liver in Systemic Diseases","first-page":"337","article-title":"The liver in transplantation","author":"Crawford","year":"1993"},{"key":"10.1016\/j.jceh.2014.10.002_bib57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib58","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bbmt.2011.06.006","article-title":"The incidence of venoocclusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade","volume":"17","author":"Carreras","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib59","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.bbmt.2012.10.023","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, Current status of treatment, and future Directions","volume":"19","author":"Richardson","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib60","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00007890-198506000-00005","article-title":"The clinical course of 53 patients with venocclusive disease of the liver after marrow transplantation","volume":"39","author":"McDonald","year":"1985","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.10.002_bib61","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.12558","article-title":"BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation","volume":"163","author":"Dignan","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jceh.2014.10.002_bib62","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1182\/blood-2014-03-551630","article-title":"How I treat sinusoidal obstruction syndrome","volume":"123","author":"Chao","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2014.10.002_bib63","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood-2008-07-169342","article-title":"Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation","volume":"112","author":"Cutler","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2014.10.002_bib64","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood-2006-09-046219","article-title":"Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation","volume":"109","author":"Cutler","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2014.10.002_bib65","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.bbmt.2010.02.016","article-title":"Prediction of veno-occlusive disease using biomarkers of endothelial injury","volume":"16","author":"Cutler","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib66","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2012.08.015","article-title":"Focus: a bad transition and a good step forward","volume":"57","author":"Friedman","year":"2012","journal-title":"Hepatol"},{"key":"10.1016\/j.jceh.2014.10.002_bib67","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/bjs.5278","article-title":"A\u00a0population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer","volume":"93","author":"Leporrier","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.jceh.2014.10.002_bib68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.suronc.2007.04.010","article-title":"Liver resection for colorectal liver metastasis","volume":"16","author":"Lochan","year":"2007","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jceh.2014.10.002_bib69","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejso.2013.12.009","article-title":"Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome","volume":"40","author":"Imai","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jceh.2014.10.002_bib70","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","article-title":"Trends in long-term survival following liver resection for hepatic colorectal metastases","volume":"235","author":"Choti","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.jceh.2014.10.002_bib71","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1200\/JCO.2004.00.6155","article-title":"extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?","volume":"23","author":"Khatri","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jceh.2014.10.002_bib72","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","article-title":"Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival","volume":"240","author":"Adam","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jceh.2014.10.002_bib73","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0140-6736(11)60613-2","article-title":"Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomized phase 3 MRC COIN trial","volume":"377","author":"Maughan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2014.10.002_bib74","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/pbc.22202","article-title":"Veno-occlusive disease as a complication of preoperative chemotherapy for Wilms tumor: a clinic-pathological analysis","volume":"53","author":"Jagt","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jceh.2014.10.002_bib75","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pbc.22841","article-title":"Veno-occlusive disease in pediatric patients affected by Wilms tumor","volume":"57","author":"Cesaro","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jceh.2014.10.002_bib76","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jceh.2014.10.002_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.jceh.2014.10.002_bib78","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.jceh.2014.10.002_bib79","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/SLA.0b013e3181c79403","article-title":"Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome","volume":"251","author":"Soubrane","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jceh.2014.10.002_bib80","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1872-034X.2012.01114.x","article-title":"Oxaliplatin-related sinusoidal obstruction syndrome mimicking metastatic liver tumors","volume":"43","author":"Arakawa","year":"2013","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2014.10.002_bib81","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1245\/s10434-010-1317-4","article-title":"Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy","volume":"18","author":"Tamandl","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jceh.2014.10.002_bib82","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.5719","article-title":"Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases","volume":"94","author":"Zorzi","year":"2007","journal-title":"Br J Surg"},{"key":"10.1016\/j.jceh.2014.10.002_bib83","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A\u00a0simple noninvasive index can predict both significant fibrosis and cirrhosis inpatients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.10.002_bib84","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.10.002_bib85","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1245\/s10434-013-2915-8","article-title":"Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases","volume":"20","author":"van den Brock","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jceh.2014.10.002_bib86","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/hpb.12010","article-title":"An experimental study to identify the potential role of pharmacogenomics in determining the occurrence of oxaliplatin-induced liver injury","volume":"15","author":"Robinson","year":"2013","journal-title":"HPB"},{"key":"10.1016\/j.jceh.2014.10.002_bib87","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0360-3016(94)00418-K","article-title":"Hepatic toxicity resulting from cancer treatment","volume":"31","author":"Lawrence","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jceh.2014.10.002_bib88","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V99.7.2310","article-title":"Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy","volume":"99","author":"Rajvanish","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2014.10.002_bib89","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12185-013-1275-2","article-title":"Incidence of sinusoidal obstruction syndrome following Mylotarg (gembuzumab ozogamicin): a prospective observational study of 482 patients in routine clinical practice","volume":"97","author":"Tallman","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jceh.2014.10.002_bib90","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/00000478-199906000-00015","article-title":"Recurring fibro-obliterative venopathy in liver allografts","volume":"23","author":"Fiel","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jceh.2014.10.002_bib91","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/lt.21451","article-title":"Central perivenulitis: a common and potentially important finding in late posttransplant liver biopsies","volume":"14","author":"Hubscher","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.10.002_bib92","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1399-3046.2004.00171.x","article-title":"Early graft failure due to a veno-occlusive disease after a pediatric living donor liver transplantation","volume":"8","author":"Izaki","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib93","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/lt.22282","article-title":"Significance of isolated hepatic veno-occlusive disease\/sinusoidal obstruction syndrome after liver transplantation","volume":"17","author":"Sebagh","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.10.002_bib94","doi-asserted-by":"crossref","first-page":"376","DOI":"10.18433\/J36G6X","article-title":"Hepatotoxic botanicals \u2013 an evidence-based systematic review","volume":"16","author":"Abdualmjid","year":"2013","journal-title":"J\u00a0Pharm Pharm Sci"},{"key":"10.1016\/j.jceh.2014.10.002_bib95","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00007611-199911000-00011","article-title":"Acute hepatitis after ingestion of herbs","volume":"92","author":"Shad","year":"1999","journal-title":"South Med J"},{"key":"10.1016\/j.jceh.2014.10.002_bib96","first-page":"1689","article-title":"Hepatitis after the use of germander, a herbal remedy","volume":"154","author":"Lalibert\u00e9","year":"1996","journal-title":"CMAJ"},{"key":"10.1016\/j.jceh.2014.10.002_bib97","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4065\/76.7.688","article-title":"Prevalence of use of herbal products by adults in the Minneapolis\/St Paul, Minn, metropolitan area","volume":"76","author":"Harnack","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jceh.2014.10.002_bib98","first-page":"95","article-title":"Pyrrolizidine alkaloid plants, metabolism and toxicity","volume":"8","author":"Stegelmeier","year":"1999","journal-title":"J\u00a0Nat Toxins"},{"key":"10.1016\/j.jceh.2014.10.002_bib99","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1368980000000586","article-title":"The efficacy and safety of comfrey","volume":"3","author":"Stickel","year":"2000","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.jceh.2014.10.002_bib100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0165-6147(02)02106-5","article-title":"Comfrey toxicity revisited","volume":"23","author":"Rode","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jceh.2014.10.002_bib101","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1440-1746.1990.tb01827.x","article-title":"Hepatic veno-occlusive disease associated with comfrey ingestion","volume":"5","author":"Yeong","year":"1990","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2014.10.002_bib102","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0344-0338(99)80108-3","article-title":"Fatal course of veno-occlusive disease of the liver (endophlebitis hepatica obliterans) in a preterm infant","volume":"195","author":"Consolato","year":"1999","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.jceh.2014.10.002_bib103","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-117-2-165","article-title":"The myth of beneficial nature: the risk of herbal preparations","volume":"117","author":"Huxtable","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2014.10.002_bib104","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jceh.2014.10.002_bib105","article-title":"Hirmi Valley liver disease: a disease associated with exposure to pyrrolizidine alkaloids and DDT","author":"Robinson","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.10.002_bib106","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2710.2002.00444.x","article-title":"Herbal medication: potential for adverse interactions with analgesic drugs","volume":"27","author":"Abebe","year":"2002","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.jceh.2014.10.002_bib107","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jhep.2007.06.014","article-title":"Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife\u00ae products","volume":"47","author":"Schoepfer","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.10.002_bib108","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0002-9343(89)80492-9","article-title":"Comfrey herb tea-induced hepatic venoocclusive disease","volume":"87","author":"Bach","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.jceh.2014.10.002_bib109","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/bmj.295.6591.183","article-title":"Veno-occlusive disease of the liver secondary to ingestion of comfrey","volume":"295","author":"Weston","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jceh.2014.10.002_bib110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF01991912","article-title":"Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea","volume":"154","author":"Sperl","year":"1995","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jceh.2014.10.002_bib111","first-page":"33","article-title":"Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids","volume":"13","author":"Gao","year":"2012","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.jceh.2014.10.002_bib112","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0022-3476(76)80988-2","article-title":"Familial hepatic venoocclusive disease with probable immune deficiency","volume":"88","author":"Mallis","year":"1976","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jceh.2014.10.002_bib113","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ng1780","article-title":"Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease","volume":"38","author":"Roscioli","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jceh.2014.10.002_bib114","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jaci.2012.02.054","article-title":"Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome","volume":"130","author":"Cliffe","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jceh.2014.10.002_bib115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.clim.2012.07.016","article-title":"Hepatic veno-occlusive disease with immunodeficiency (VODI): first reported case in the U.S. and identification of a unique mutation in SP110","volume":"145","author":"Wang","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jceh.2014.10.002_bib116","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/pd.1759","article-title":"The first prenatal diagnosis for veno-occlusive disease and immunodeficiency syndrome, an autosomal recessive condition associated with mutations in SP110","volume":"27","author":"Cliffe","year":"2007","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jceh.2014.10.002_bib117","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00335-001-3015-9","article-title":"Source and component genes of a 6-200 Mb gene cluster in the house mouse","volume":"12","author":"Weichenhan","year":"2001","journal-title":"Mamm Genome"},{"key":"10.1016\/j.jceh.2014.10.002_bib118","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver","volume":"49","author":"DeLeve","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.10.002_bib119","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib120","first-page":"737","article-title":"Treatment of severe venoocclusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population","volume":"92","author":"Richardson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2014.10.002_bib121","first-page":"1122","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study","volume":"111","author":"Chopra","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jceh.2014.10.002_bib122","article-title":"Defibrotide (DF) in the treatment of hepatic veno-occlusive disease (VOD) in stem cell transplant (SCT) and non-SCT patients (Pts): early intervention improves outcome: updated results of a treatment IND expanded accessprotocol","volume":"118","author":"Richardson","year":"2011","journal-title":"Blood (ASH Annual Meeting Abstract)"},{"key":"10.1016\/j.jceh.2014.10.002_bib123","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/bmt.2013.101","article-title":"Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?","volume":"48","author":"Yoon","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib124","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/pbc.24859","article-title":"Non-activated protein C rescue treatment in Wilms tumour associated hepatic sinusoidal obstructive syndrome","volume":"61","author":"De Leonardia","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jceh.2014.10.002_bib125","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.bbmt.2012.11.011","article-title":"High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients","volume":"19","author":"Myers","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib126","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.bmt.1702386","article-title":"Transjugular intrahepatic porto- systemic shunt (TIPS) for severe veno- occlusive disease of the liver following bone marrow transplantation","volume":"25","author":"Azoulay","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib127","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/jlts.2001.0070154","article-title":"Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlu- sive disease","volume":"7","author":"Rajvanshi","year":"2001","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1034\/j.1600-0676.2001.210105.x","article-title":"Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation-role of transjugular intrahepatic portosystemic shunt (TIPS)","volume":"21","author":"Zenz","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.jceh.2014.10.002_bib129","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00007890-199004000-00035","article-title":"Successful treatment of hepatic venoocclusive disease in a bone marrow transplant patient with orthotopic liver transplantation","volume":"49","author":"Nimer","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.10.002_bib130","first-page":"421","article-title":"Orthotopic liver transplantation for lifethreatening veno-occlusive disease of the liver after allogeneic bone marrow transplant","volume":"8","author":"Rappaport","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib131","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1034\/j.1600-6143.2002.20815.x","article-title":"A\u00a0successful liver transplantation for refractory hepatic veno-occlusive disease originating from cord blood transplantation","volume":"2","author":"Kim","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib132","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.exphem.2012.04.004","article-title":"How can we reduce hepatic veno-occlusive disease\u2013related deaths after allogeneic stem cell transplantation?","volume":"40","author":"Johnson","year":"2012","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jceh.2014.10.002_bib133","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2014.10.002_bib134","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","article-title":"Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation","volume":"101","author":"McDonald","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2014.10.002_bib135","first-page":"3599","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2014.10.002_bib136","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V76.9.1867.1867","article-title":"Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens","volume":"76","author":"Clift","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2014.10.002_bib137","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00277-004-0982-4","article-title":"Decreased incidence of hepatic venoocclusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan? Cyclophosphamide for allogeneic bone marrow transplantation","volume":"84","author":"Lee","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jceh.2014.10.002_bib138","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.bbmt.2011.06.006","article-title":"The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade","volume":"17","author":"Carreras","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib139","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib140","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Essell","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2014.10.002_bib141","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bmt.1703342","article-title":"A\u00a0randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib142","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2014.10.002_bib143","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","article-title":"Immunomodulatory effects of ursodeoxycholic acid on immune responses","volume":"16","author":"Yoshikawa","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.10.002_bib144","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial","volume":"79","author":"Attal","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2014.10.002_bib145","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00007890-199604150-00014","article-title":"Low molecular-weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients","volume":"61","author":"Or","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.10.002_bib146","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0609.1991.tb01859.x","article-title":"Prophylactic heparin does not prevent liver veno-occlusive disease following autologic bone marrow transplantation","volume":"47","author":"Marsa-Vila","year":"1991","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jceh.2014.10.002_bib147","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.bmt.1701068","article-title":"Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver","volume":"21","author":"Fisher","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib148","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bmt.1701321","article-title":"Parenteral glutamine protects hepatic function during bone marrow transplantation","volume":"22","author":"Brown","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jceh.2014.10.002_bib149","doi-asserted-by":"crossref","first-page":"440","DOI":"10.6002\/ect.2012.0265","article-title":"Coexisting or underlying risk factors of hepatic veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients receiving prophylaxis","volume":"11","author":"G\u00f6kce","year":"2013","journal-title":"Exp Clin Transpl"},{"key":"10.1016\/j.jceh.2014.10.002_bib150","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/cncr.23099","article-title":"Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases","volume":"110","author":"Ribero","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2014.10.002_bib151","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","article-title":"Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis","volume":"56","author":"Rubbia-Brandt","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.jceh.2014.10.002_bib152","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314004228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314004228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:02:09Z","timestamp":1760853729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688314004228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":152,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0973688314004228"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2014.10.002","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sinusoidal Obstruction Syndrome (Hepatic Veno-Occlusive Disease)","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2014.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 INASL. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}